NCT04965103

Brief Summary

Randomized controlled trial examining superior capsule reconstruction versus tendon repair with graft interposition in "irreparable" rotator cuff tears.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 7, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
Last Updated

July 16, 2021

Status Verified

June 1, 2021

Enrollment Period

4.9 years

First QC Date

June 21, 2021

Last Update Submit

July 6, 2021

Conditions

Keywords

irreparable

Outcome Measures

Primary Outcomes (4)

  • American Shoulder and Elbow Surgeon Outcome - patient portion

    American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)

    24 months

  • American Shoulder and Elbow Surgeon Outcome - patient portion

    American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)

    12 months

  • American Shoulder and Elbow Surgeon Outcome - patient portion

    American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)

    6 months

  • American Shoulder and Elbow Surgeon Outcome - patient portion

    American Shoulder and Elbow Surgeon Outcome - patient portion (minimum score = 0, maximum score = 100, best outcome = 100)

    3 months

Secondary Outcomes (9)

  • Western Ontario Rotator Cuff Index

    24 months

  • Western Ontario Rotator Cuff Index

    12 months

  • Western Ontario Rotator Cuff Index

    6 months

  • Western Ontario Rotator Cuff Index

    3 months

  • Disabilities of the Arm, Shoulder and Hand - QuickDASH

    24 months

  • +4 more secondary outcomes

Study Arms (2)

Bridging

ACTIVE COMPARATOR

Tendon repair with graft interposition

Procedure: Bridging

SCR

EXPERIMENTAL

Superior Capsule reconstruction

Procedure: SCR

Interventions

SCRPROCEDURE

Superior Capsule reconstruction

SCR
BridgingPROCEDURE

Tendon repair with graft interposition

Bridging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Large to massive rotator cuff tear (with or without subscapularis tear) that may possibly be irreparable without the use of graft materials (confirmed intra-operatively)
  • Either primary tear or re-tear after previous repair
  • Radiographic evidence of Hamada stage 1-3, with or without Samilson \& Prieto mild osteoarthritis (\<3mm inferior osteophyte)

You may not qualify if:

  • Primary glenohumeral osteoarthritis: radiographic evidence of Samilson \& Prieto classification moderate or greater
  • Cuff tear arthropathy (CTA): radiographic evidence of Hamada stage 4 or above
  • Inflammatory joint disease of the shoulder (e.g. rheumatoid arthritis)
  • Medical issues precluding surgery
  • Unwilling or unable to complete study outcomes
  • Worker's Compensation Claim or litigation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Rotator Cuff Injuries

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Study Officials

  • Ian Lo, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participant and research assistant collecting outcomes were blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2021

First Posted

July 16, 2021

Study Start

January 1, 2016

Primary Completion

November 7, 2020

Study Completion

December 31, 2020

Last Updated

July 16, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

No plan to share individual participant data.